Differential response of iron metabolism to oxidative stress generated by antimycin A and nitrofurantoin

Biochimie

Volumn 88, Issue 6, 2006, Pages 575-581

  Sturm, Brigitte ^a   Twaroch, Teresa ^a   Knapitsch, Birgit ^a   Czingraber, Sylvia ^a   Ternes, Nina ^a   Goldenberg, Hans ^a   Scheiber Mojdehkar, Barbara ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

HepG2 cells; Labile iron pool; Non transferrin bound iron; Oxidative stress; Transferrin bound iron

Indexed keywords

ANTIMYCIN A1; EBSELEN; IRON CHELATING AGENT; MITOCHONDRIAL ENZYME; NITROFURANTOIN; OXYGEN RADICAL; PEROXIDE; TRANSFERRIN; IRON;

ARTICLE; CELL STRAIN HEPG2; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; IRON METABOLISM; IRON TRANSPORT; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; OXIDATIVE STRESS; RESPIRATORY CHAIN; DRUG EFFECT; METABOLISM; TUMOR CELL LINE;

ANTIMYCIN A; CELL LINE, TUMOR; HUMANS; IRON; IRON CHELATING AGENTS; NITROFURANTOIN; OXIDATIVE STRESS;

EID: 33745936535     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2005.08.011     Document Type: Article

References (53)

1. Baker E., and Morgan E.H. Iron transport. In: Brock J.H., Halliday J.W., Pippard M.J., and Powell L.W. (Eds). Iron Metabolism in Health and Disease (1994), Saunders W.B., London, England 63-96
2. Harford J., Rouault T.A., Klausner R.D., and The control of cellular iron. In: Brock J.H., Halliday J.W., Pippard M.J., and Powell L.W. (Eds). Iron Metabolism in Health and Disease (1994), Saunders W.B., London, England 123-150
3. Kühn L.C., and Hentze M.W. Coordination of cellular iron metabolism by post-transcriptional gene regulation. J. Inorg. Biochem. 47 (1992) 183-195
4. Klausner R.D., Rouault T.A., and Harford J.B. Regulating the fate of messenger RNA-The control of cellular iron metabolism. Cell 72 (1993) 19-28
5. Craven C.M., Alexander J., Eldridge M., Kushner J.P., Bernstein S., and Kaplan J. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc. Natl. Acad. Sci. USA 84 (1987) 3457-3461
6. Hamill R.L., Woods J.C., and Cook B.A. Congenital antransferrinemia. A case report and review of the literature. Am. J. Clin. Pathol. 96 (1987) 215-218
7. Wang W.C., Ahmed N., and Hanna M. Non-transferrin-bound iron in long-term transfusion in children with congenital anemias. J. Pediatr. 108 (1986) 552-557
8. Grootveld M., Bell J.D., Halliwell B., Aruoma O.J., Bomford A., and Sadler P.J. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis: characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J. Biol. Chem. 264 (1989) 4417-4422
9. Halliwell B., Aruoma O.I., Mufti G., and Bomford A. Bleomycin detectable iron in serum from leukaemic patients before and after chemotherapy. FEBS Lett. 241 (1988) 202-204
10. Harrison P., Marwah S.S., Hughes R.T., and Bareford D. Non-transferrin-bound iron and neutropenia after cytotoxic chemotherapy. J. Clin. Pathol. 47 (1994) 350-362
11. Bradley S.J., Gosriwitana I., Srichairatanakool S., and Porter J.B. Non-transferrin-bound iron induced by myeloablative chemotherapy. Br. J. Haematol. 99 (1997) 337-343
12. Dürken M., Nielsen P., Knobel S., Finckh B., Herrnring C., Dresow B., Kohlschutter B., Stockschlader M., Kruger W.H., and Kohlschutter A. Non-transferrin-bound iron in serum of patients receiving bone marrow transplants. Free Rad. Biol. Med. 22 (1997) 1159-1163
13. Banyai S., Rainer V., Derfler K., Druml W., Hörl W., and Sunder-Plasmmann G. Bleomycin-detectable free iron (BDI) is present in patients on intravenous (IV) iron therapy. J. Am. Soc. Nephrol. 9 (1998) 199A
14. Eschbach J.W., and Adamson J.W. Iron-overlaod in renal failure patients: changes since the introduction of erythropoietin therapy. Kidney Int. 55 (1999) S35-S43
15. Besarab A., Frinak S., and Yee J. An indistinct balance: the safety and efficacy of parenteral iron therapy. J. Am. Soc. Nephrol. 10 (1999) 2029-2043
16. Richardson D.R., and Baker E. The uptake of inorganic iron complexes by human melanoma cells. Biochim. Biophys. Acta 1093 (1991) 20-28
17. Kovar J., and Franek F. Iron compounds at high concentrations enable hybridoma growth in a protein-free medium. Biotechnol. Lett. 9 (1987) 259-264
18. Neumannova V., Richardson D.R., Kriegerbeckova K., and Kovar J. Growth of human tumor cell lines in transferrin-free, low-iron medium. In Vitro Cell. Dev. Biol. Anim. 31 (1995) 625-632
19. Kaplan J., Jordan I., and Sturrock A. Regulation of the transferrin-independent iron transport system in cultured cells. J. Biol. Chem. 266 (1991) 2997-3004
20. Richardson D.R., and Baker E. The effect of desferrioxamine and ferric ammonium citrate on the uptake of iron by the membrane iron-binding component of human melanoma cells. Biochim. Biophys. Acta 1103 (1992) 275-280
21. Hamazaki S., and Glass J. Non-transferrin dependent Fe-59 uptake in phytohemagglutinin-stimulated human peripheral lymphocytes. Exp. Hematol. 20 (1992) 436-441
22. Inman R.S., and Wessling-Resnick M. Characterization of transferrin-independent iron transport in K562 cells. Unique properties provide evidence for multiple pathways of iron uptake. J. Biol. Chem. 268 (1993) 8521-8528
23. Parkes J.G., and Templeton D.M. Iron transport and subcellular distribution in HepG2 hepatocarcinoma cells. Ann. Clin. Lab. Sci. 24 (1994) 509-520
24. Parkes J.G., Randell E.W., Olivieri N.F., and Templeton D.M. Modulation by iron loading and chelation of the uptake of non transferrin bound iron by human liver cells. Biochim. Biophys. Acta 1243 (1995) 373-380
25. Kriegerbeckova K., Döpper L., Scheiber B., Kovar J., and Goldenberg H. Non-transferrin iron uptake by HeLa cells cultured in serum-free media with different sources of iron supply. Eur. J. Clin. Chem. Clin. Biochem. 33 (1995) 791-797
26. 3+ transport by iron-loaded cardiac myocytes. Toxicology 117 (1997) 141-151
27. Scheiber B., Zimmermann I., Dresow B., and Goldenberg H. Differential response of non-transferrin bound iron uptake in rat liver cells on long-term and short term treatment with iron. J. Hepatol. 31 (1999) 61-70
28. Sarkar B. State of iron(III) in normal human serum: low molecular weight and protein ligands besides transferrin. Can. J. Biochem. 48 (1970) 1339-1350
29. Brunner-Döpper L., Kriegerbeckova K., Kovar J., and Goldenberg H. Pitfalls in assessing specificity and affinity of non-transferrin bound iron uptake. Anal. Biochem. 261 (1998) 128-130
30. Richardson D.R., and Ponka P. Identification of a mechanism of iron by cells which is stimulated by hydroxyl radicals generated via the iron-catalysed Haber-Weiss reaction. Biochim. Biophys. Acta 1269 (1995) 105-114
31. 3+ to transferrin in the absence of synergistic anions. J. Biol. Chem. 250 6 (1975) 2177-2181
32. Rossi L., Silva J.M., McGirr L.G., and O'Brien P.J. Nitrofurantoin-mediated oxidative stress cytotoxicity in isolated rat hepatocytes. Biochem. Pharmacol. 37 (1988) 3109-3117
33. Gordeuk V., Bacon B.R., and Brittenham G.M. Iron overload: causes and consequences. Annu. Rev. Nutr. 7 (1987) 485-508
34. Halliwell B., and Gutteridge J.M.C. Role of free radicals and catalytic metal ions in human disease: an overview. Meth. Enzymol. 186 (1990) 1-85
35. Ryan T.P., and Aust S.D. The role of iron in oxygen-mediated toxicities. Crit. Rev. Toxicol. 22 (1992) 119-141
36. Mintoti G., and Aust S.D. The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide. J. Biol. Chem. 262 (1987) 1098-1104
37. Kuo C.F., Mashine T., and Fridovich I. Alpha, beta-dihydroxyl-isovalerate dehydratase: a superoxide-dependent enzyme. J. Biol. Chem. 262 (1987) 4724-4727
38. Agrawal R., Sharma P.K., and Rao G.S. Release of iron from ferritin by metabolites of benzene and superoxide radical generating agents. Toxicology 168 (2001) 223-230
39. Keyer K., and Imlay J.A. Superoxide accelerates DNA damage by elevating free iron levels. Proc. Natl. Acad. Sci. USA 93 (1996) 13635-13640
40. Gardner P.R., Raineri R., and Epstein L.B. Superoxide radical and iron modulate aconitase activity. J. Biol. Chem. 270 (1995) 13399-13405
41. Cairo C., Tacchini L., Pogliaghi G., Anzon E., Tomasi A., and Benelli-Zazzera A. Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. J. Biol. Chem. 270 (1995) 700-703
42. Tsuji Y., Ayaki H., Whitman S.P., Morrow C.S., Torti S.V., and Torti F.M. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol. Cell. Biol. 20 (2000) 5818-5827
43. Cairo G., Castrusini E., Minotti G., and Bernelli-Zazzera A. Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: a protective stratagem against oxidative injury. FASEB J. 10 (1996) 1326-1335
44. Pantopoulos K., Mueller S., Atzberger A., Ansorge W., Stremmel W., and Hentze M.W. Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress. J. Biol. Chem. 272 (1997) 9802-9808
45. Martinez P.G., Winston G.W., Metashdickey C., O'Hara S.C.M., and Livingstone D.R. NF-stimulated reactive oxygen species production and genotoxicity in digestive gland microsomes and cytosol of the common mussel. Toxicol. Appl. Pharmacol. 131 (1995) 332-341
46. Nakamura Y., Feng Q., Kumagai T., Torikai K., Ohigashi H., Osawa T., Noguchi N., Niki E., and Uchida K. Ebselen, a glutathione peroxidase mimetic seleno-organic compound, as a multifunctional antioxidant. J. Biol. Chem. 277 (2002) 2678-2694
47. Scheiber B., and Goldenberg H. Uptake of iron by isolated rat hepatocytes from a hydrophilic impermeant ferric chelate, Fe(III)DTPA. Arch. Biochem. Biophys. 326 (1996) 185-192
48. Grootveld M., Bell J.D., Halliwell B., Aruoma O.J., Bomford A., and Sadler P.J. Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis: characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J. Biol. Chem. 264 (1989) 4417-4422
49. Richardson D.R., and Baker E. The effect of desferrioxamine and ferric ammonium citrate on the uptake of iron by the membrane iron-binding component of human melanoma cells. Biochim. Biophys. Acta 1103 (1992) 275-280
50. Richardson D.R., Chua A.C., and Baker E. Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: implications for the pathogenesis of iron-overload disease. J. Lab. Clin. Med. 133 (1999) 144-151
51. Andrews N.C. The iron transporter DMT1. Int. J. Biochem. Cell Biol. 31 (1999) 991-994
52. Nunez-Millacura C., Tapia V., Munoz P., Maccioni R.B., and Nunez M.T. An oxidative stress-mediated positive-feedback iron uptake loop in neuronal cells. J. Neurochem. 82 (2002) 240-248
53. Petrat F., de Groot H., and Rauen U. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem. J. 356 (2001) 61-69